Jurado S et al. |
Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures. |
2010 |
Osteoporos Int |
pmid:19436932
|
Moran CS et al. |
Association of PPARgamma allelic variation, osteoprotegerin and abdominal aortic aneurysm. |
2010 |
Clin. Endocrinol. (Oxf) |
pmid:19438902
|
Yilmaz Y et al. |
Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease. |
2010 |
Scand. J. Clin. Lab. Invest. |
pmid:20942739
|
Grauslund J et al. |
Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes? |
2010 |
Scand. J. Clin. Lab. Invest. |
pmid:20205614
|
Wang L et al. |
Effects and mechanism of aromatic aminoketone SY0916 on osteoclastic bone destruction. |
2010 |
Acta Pharmacol. Sin. |
pmid:20208552
|
Zagura M et al. |
Association of osteoprotegerin with aortic stiffness in patients with symptomatic peripheral artery disease and in healthy subjects. |
2010 |
Am. J. Hypertens. |
pmid:20224558
|
Jurado S et al. |
Effect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts. |
2010 |
J. Cell. Biochem. |
pmid:20225238
|
Ma H et al. |
Effects of diet-induced obesity and voluntary wheel running on bone properties in young male C57BL/6J mice. |
2010 |
Calcif. Tissue Int. |
pmid:20229059
|
Jono S et al. |
Serum osteoprotegerin levels and long-term prognosis in subjects with stable coronary artery disease. |
2010 |
J. Thromb. Haemost. |
pmid:20230427
|
Kobayashi-Sakamoto M et al. |
Osteoprotegerin induces cytoskeletal reorganization and activates FAK, Src, and ERK signaling in endothelial cells. |
2010 |
Eur. J. Haematol. |
pmid:20331738
|
Chen CH et al. |
Soluble receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation. |
2010 |
Clin. Rheumatol. |
pmid:20690034
|
Lee HJ et al. |
Heme oxygenase-1 protects human periodontal ligament cells against substance P-induced RANKL expression. |
2010 |
J. Periodont. Res. |
pmid:20337895
|
Røysland R et al. |
Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial. |
2010 |
Am. Heart J. |
pmid:20691834
|
Noheria A et al. |
Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension. |
2010 |
Am. J. Hypertens. |
pmid:20339356
|
Wiens M et al. |
The role of biosilica in the osteoprotegerin/RANKL ratio in human osteoblast-like cells. |
2010 |
Biomaterials |
pmid:20673584
|
Mogi M and Kondo A |
ELISA for RANKL-OPG complex in mouse sera. |
2010 |
J Immunoassay Immunochem |
pmid:20391022
|
Vik A et al. |
Relation between serum osteoprotegerin and carotid intima media thickness in a general population - the Tromsø Study. |
2010 |
J. Thromb. Haemost. |
pmid:20738762
|
Dalbeth N et al. |
Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion. |
2010 |
Arthritis Res. Ther. |
pmid:20796300
|
Cody JJ et al. |
Arming a replicating adenovirus with osteoprotegerin reduces the tumor burden in a murine model of osteolytic bone metastases of breast cancer. |
2010 |
Cancer Gene Ther. |
pmid:20798695
|
Fanourakis G et al. |
Expression of receptor activator of NF-κB ligand and osteoprotegerin in peripheral giant cell granulomas of the jaws. |
2010 |
J. Oral Pathol. Med. |
pmid:20701665
|
Camozzi V et al. |
Persistent increase of osteoprotegerin levels after cortisol normalization in patients with Cushing's syndrome. |
2010 |
Eur. J. Endocrinol. |
pmid:19793762
|
Rooney T et al. |
Synovial tissue rank ligand expression and radiographic progression in rheumatoid arthritis: observations from a proof-of-concept randomized clinical trial of cytokine blockade. |
2010 |
Rheumatol. Int. |
pmid:19847430
|
Vanella L et al. |
HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage. |
2010 |
Bone |
pmid:19853072
|
Nezami N et al. |
Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathy. |
2010 |
Clin. Biochem. |
pmid:20727867
|
Ochi H et al. |
The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival. |
2010 |
J. Orthop. Res. |
pmid:19890995
|
Zhang Y et al. |
Osteogenic properties of hydrophilic and hydrophobic titanium surfaces evaluated with osteoblast-like cells (MG63) in coculture with human umbilical vein endothelial cells (HUVEC). |
2010 |
Dent Mater |
pmid:20728208
|
Jensen JK et al. |
Osteoprotegerin concentrations and prognosis in acute ischaemic stroke. |
2010 |
J. Intern. Med. |
pmid:19895657
|
Zupan J et al. |
Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women. |
2010 |
J. Steroid Biochem. Mol. Biol. |
pmid:19896533
|
Walker CG et al. |
Osteopontin is required for unloading-induced osteoclast recruitment and modulation of RANKL expression during tooth drift-associated bone remodeling, but not for super-eruption. |
2010 |
Bone |
pmid:20828639
|
Rianthavorn P et al. |
Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium. |
2010 |
Pediatr. Nephrol. |
pmid:20676692
|
Le Heron L et al. |
Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone. |
2010 |
J. Cyst. Fibros. |
pmid:20005786
|
Jules J et al. |
Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis. |
2010 |
Expert Opin. Ther. Targets |
pmid:20678025
|
Fong JE et al. |
Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase. |
2010 |
J. Biol. Chem. |
pmid:20679341
|
Kim M et al. |
Td92, an outer membrane protein of Treponema denticola, induces osteoclastogenesis via prostaglandin E(2)-mediated RANKL/osteoprotegerin regulation. |
2010 |
J. Periodont. Res. |
pmid:20682013
|
Lossdörfer S et al. |
Aging affects the phenotypic characteristics of human periodontal ligament cells and the cellular response to hormonal stimulation in vitro. |
2010 |
J. Periodont. Res. |
pmid:20682014
|
Ostrowski MC |
A new role for OPG: putting RANKL in its place. |
2010 |
J. Bone Miner. Res. |
pmid:20684024
|
Pi M et al. |
Impaired osteoblast function in GPRC6A null mice. |
2010 |
J. Bone Miner. Res. |
pmid:19874200
|
Secchiero P et al. |
Baseline serum concentrations of TRAIL in early rheumatoid arthritis: relationship with response to disease-modifying antirheumatic drugs. |
2010 |
J. Rheumatol. |
pmid:20472926
|
Scheres N et al. |
Gingival and periodontal ligament fibroblasts differ in their inflammatory response to viable Porphyromonas gingivalis. |
2010 |
J. Periodont. Res. |
pmid:19778323
|
Santos VR et al. |
Receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in sites of chronic periodontitis of subjects with poorly and well-controlled type 2 diabetes. |
2010 |
J. Periodontol. |
pmid:20476881
|
Wu XY et al. |
The relationship between the levels of gonadotropic hormones and OPG, leptin, TGF-beta1 and TGF-beta2 in Chinese adult women. |
2010 |
Clin. Chim. Acta |
pmid:20478283
|
Cawley NX et al. |
Obese carboxypeptidase E knockout mice exhibit multiple defects in peptide hormone processing contributing to low bone mineral density. |
2010 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:20460579
|
Jiang R et al. |
High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer. |
2010 |
Int. J. Cancer |
pmid:19728335
|
Rhee EJ et al. |
The relationship between Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) gene polymorphism and aortic calcification in Korean women. |
2010 |
Endocr. J. |
pmid:20431232
|
Wiwanitkit V |
Osteoprotegerin and acute ischaemic stroke. |
2010 |
J. Intern. Med. |
pmid:20433585
|
Qian Y and Huang HZ |
The role of RANKL and MMP-9 in the bone resorption caused by ameloblastoma. |
2010 |
J. Oral Pathol. Med. |
pmid:20412401
|
Qian H et al. |
Activation of cannabinoid receptor CB2 regulates osteogenic and osteoclastogenic gene expression in human periodontal ligament cells. |
2010 |
J. Periodont. Res. |
pmid:20412420
|
Lamoureux F et al. |
Regulation of osteoprotegerin pro- or anti-tumoral activity by bone tumor microenvironment. |
2010 |
Biochim. Biophys. Acta |
pmid:19733222
|
Mine Y et al. |
Impact of titanium ions on osteoblast-, osteoclast- and gingival epithelial-like cells. |
2010 |
J Prosthodont Res |
pmid:19733525
|
Chang IC et al. |
Platelet-rich fibrin modulates the expression of extracellular signal-regulated protein kinase and osteoprotegerin in human osteoblasts. |
2010 |
J Biomed Mater Res A |
pmid:20623670
|
Martin-Bautista E et al. |
Improvement of bone formation biomarkers after 1-year consumption with milk fortified with eicosapentaenoic acid, docosahexaenoic acid, oleic acid, and selected vitamins. |
2010 |
Nutr Res |
pmid:20579524
|
Tyrovola JB et al. |
Relation of soluble RANKL and osteoprotegerin levels in blood and gingival crevicular fluid to the degree of root resorption after orthodontic tooth movement. |
2010 |
J Oral Sci |
pmid:20587957
|
McAllister SS and Weinberg RA |
Tumor-host interactions: a far-reaching relationship. |
2010 |
J. Clin. Oncol. |
pmid:20644094
|
Gupta N et al. |
IL-3 inhibits human osteoclastogenesis and bone resorption through downregulation of c-Fms and diverts the cells to dendritic cell lineage. |
2010 |
J. Immunol. |
pmid:20644169
|
Pedersen ER et al. |
Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris. |
2010 |
Atherosclerosis |
pmid:20621297
|
Long L et al. |
Dickkopf-1 as potential biomarker to evaluate bone erosion in systemic lupus erythematosus. |
2010 |
J. Clin. Immunol. |
pmid:20589421
|
Odiere MR et al. |
Protein deficiency and nematode infection during pregnancy and lactation reduce maternal bone mineralization and neonatal linear growth in mice. |
2010 |
J. Nutr. |
pmid:20660285
|
Saito-Yabe M et al. |
PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) results in decreased uptake into rats and human liver. |
2010 |
J. Pharm. Pharmacol. |
pmid:20663032
|
Aoki S et al. |
Function of OPG as a traffic regulator for RANKL is crucial for controlled osteoclastogenesis. |
2010 |
J. Bone Miner. Res. |
pmid:20560139
|
Byron CR et al. |
In vitro expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in cultured equine articular cells. |
2010 |
Am. J. Vet. Res. |
pmid:20513175
|
Jilka RL et al. |
Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms. |
2010 |
J. Bone Miner. Res. |
pmid:20533302
|
Paternoster L et al. |
OPG and RANK polymorphisms are both associated with cortical bone mineral density: findings from a metaanalysis of the Avon longitudinal study of parents and children and gothenburg osteoporosis and obesity determinants cohorts. |
2010 |
J. Clin. Endocrinol. Metab. |
pmid:20534768
|
van Tuyl LH et al. |
Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis. |
2010 |
Ann. Rheum. Dis. |
pmid:20525836
|
Zhang L et al. |
Cell-based osteoprotegerin therapy for debris-induced aseptic prosthetic loosening on a murine model. |
2010 |
Gene Ther. |
pmid:20428210
|
Kim YG et al. |
Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes. |
2010 |
Arthritis Rheum. |
pmid:20112365
|
Moreno-Rubio J et al. |
Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis. |
2010 |
Arthritis Rheum. |
pmid:20112374
|
Wagner H |
Bone diseases: Interferon regulatory factor-8 suppresses osteoclastogenesis. |
2010 |
Nat Rev Rheumatol |
pmid:20125173
|
Jiang XY et al. |
Association of LPR5 polymorphism with bone mass density and cholesterol level in population of Chinese Han. |
2010 |
Exp. Clin. Endocrinol. Diabetes |
pmid:20146170
|
Stankovic KM et al. |
Differences in gene expression between the otic capsule and other bones. |
2010 |
Hear. Res. |
pmid:20146935
|
Daoussis D et al. |
Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis. |
2010 |
Semin. Arthritis Rheum. |
pmid:19095294
|
Vik A et al. |
Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general population--the Tromsø study. |
2010 |
J. Thromb. Haemost. |
pmid:20128863
|
Hughes C et al. |
Human single-chain variable fragment that specifically targets arthritic cartilage. |
2010 |
Arthritis Rheum. |
pmid:20131274
|
Makihira S et al. |
Immobilized-OPG-Fc on a titanium surface inhibits RANKL-dependent osteoclast differentiation in vitro. |
2010 |
J Mater Sci Mater Med |
pmid:19834789
|
Kadoglou NP et al. |
Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis. |
2010 |
Eur J Vasc Endovasc Surg |
pmid:20004120
|
Secchiero P et al. |
An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction. |
2010 |
Atherosclerosis |
pmid:20015493
|
Pal SN et al. |
Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification. |
2010 |
Atherosclerosis |
pmid:20004897
|
Tomlins C and Storey A |
Cutaneous HPV5 E6 causes increased expression of Osteoprotegerin and Interleukin 6 which contribute to evasion of UV-induced apoptosis. |
2010 |
Carcinogenesis |
pmid:20884685
|
Rachner TD et al. |
Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells. |
2010 |
Cancer Lett. |
pmid:19577359
|
Lee JE et al. |
Impact of ENPP1 and MMP3 gene polymorphisms on aortic calcification in patients with type 2 diabetes in a Korean population. |
2010 |
Diabetes Res. Clin. Pract. |
pmid:20092902
|
Bai Y et al. |
Formation of bone-like tissue by dental follicle cells co-cultured with dental papilla cells. |
2010 |
Cell Tissue Res. |
pmid:20886237
|
Flyvbjerg A |
Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily. |
2010 |
Nat Rev Endocrinol |
pmid:20098449
|
Wutzl A et al. |
Bone morphogenetic proteins 2, 5, and 6 in combination stimulate osteoblasts but not osteoclasts in vitro. |
2010 |
J. Orthop. Res. |
pmid:20872578
|
Scudla V et al. |
The importance of serum levels of selected biological parameters in the diagnosis, staging and prognosis of multiple myeloma. |
2010 |
Neoplasma |
pmid:20099972
|
Wang J and Stern PH |
Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα(12) or constitutively active RhoA. |
2010 |
J. Cell. Biochem. |
pmid:20872746
|
Borsje MA et al. |
Comparison of low-intensity pulsed ultrasound and pulsed electromagnetic field treatments on OPG and RANKL expression in human osteoblast-like cells. |
2010 |
Angle Orthod |
pmid:20050743
|
Ruiz-Gaspà S et al. |
Lithocholic acid downregulates vitamin D effects in human osteoblasts. |
2010 |
Eur. J. Clin. Invest. |
pmid:20055894
|
Kochetkova EA et al. |
[Osteoprotegerin and bone mineral density in patients with chronic obstructive pulmonary disease]. |
2010 |
Ter. Arkh. |
pmid:20873238
|
Sypniewska G et al. |
Does serum osteoprotegerin level relate to fragility fracture in elderly women with low vitamin D status? |
2010 |
Med. Sci. Monit. |
pmid:20110921
|
Elias LS et al. |
Markers of bone remodeling in neoplastic and bone-related lesions. |
2010 |
Oral Surg Oral Med Oral Pathol Oral Radiol Endod |
pmid:20955951
|
Nozaki K et al. |
Effect of cyclic mechanical loading on osteoclast recruitment in periodontal tissue. |
2010 |
J. Periodont. Res. |
pmid:19602121
|
O'Sullivan EP et al. |
Osteoprotegerin is higher in peripheral arterial disease regardless of glycaemic status. |
2010 |
Thromb. Res. |
pmid:20932553
|
Tan YY et al. |
Effects of vascular endothelial growth factor (VEGF) on MC3T3-E1. |
2010 |
Orthod Craniofac Res |
pmid:21040465
|
Gallo J et al. |
[Synovial fluid from aseptically failed total hip or knee arthroplasty is not toxic to osteoblasts]. |
2010 |
Acta Chir Orthop Traumatol Cech |
pmid:21040654
|
Salah H et al. |
The clinical significance of OPG/sRANKL ratio in thalassemia patients suffering from osteopenia or osteoporosis in Egyptian patients. |
2010 |
Immunol. Invest. |
pmid:20718662
|
Lee YH et al. |
Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis. |
2010 |
Mol. Biol. Rep. |
pmid:19642016
|
Sun QF et al. |
[Effects of high mobility group box 1 in activating periodontal ligament fibroblasts to express cytokine]. |
2010 |
Hua Xi Kou Qiang Yi Xue Za Zhi |
pmid:20848944
|
Hesse E et al. |
Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. |
2010 |
J. Cell Biol. |
pmid:21173110
|
Eagan TM et al. |
Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. |
2010 |
Eur. Respir. J. |
pmid:19643942
|
Roato I et al. |
Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase. |
2010 |
PLoS ONE |
pmid:21152388
|
Kenanidis EI et al. |
Serum levels of bone turnover markers following total joint arthroplasty. |
2010 |
J Orthop Surg (Hong Kong) |
pmid:21187538
|